-
World Cancer Day 2026: Stages Of Prostate Cancer Every Patient Must Know For Swift Medical Intervention
03 Feb 2026 06:31 GMT
… have many treatments that range from surgery to radiation therapy. Medical experts … NIH explains. "In addition, docetaxel chemotherapy remains the first-line … prostate cancer, consult with your doctor about your health issues
Don …
-
Real-world head-to-head analysis shows 51% reduction in risk of death for patients with metastatic castration-sensitive prostate cancer treated with ERLEADA® (apalutamide) versus darolutamide without docetaxel through 24 months
02 Feb 2026 13:31 GMT
… Complementing randomized controlled trials, real-world evidence … were administered without docetaxel. Study investigators applied … treatment. It is unknown whether anti-epileptic medications … Development, LLC and Janssen Biotech, Inc. are Johnson …
-
Recent Advances in Mitochondria-Targeted Nano-Drug Delivery Systems for Cancer Therapy
02 Feb 2026 07:56 GMT
… cells to treatments, thereby enhancing their drug resistance.6 … biological barriers to drug delivery. Nat Biotechnol. 2015;33 … with novel triphenylphosphine-docetaxel conjugate possess hierarchical … targeting and imaging. Pharmaceutics. 2022;15(1):103 …
-
Decoding GDF15’s Role in Prostate Cancer Metabolism and Therapeutic Strategies: Insights from Chinese Medical Journal
01 Feb 2026 22:28 GMT
… sensitivity to docetaxel, underscoring its central role in modulating drug response. … paradigms in prostate cancer treatment. Ongoing and future trials will elucidate the … CM9.0000000000003876
Image Credits: Chinese Medical Journal
Keywords: Prostate cancer, …
-
Research Progress on Nano-Drug Delivery Systems for Photothermal Cancer Therapy
29 Jan 2026 21:00 GMT
… dependence on specialized medical infrastructure.57
These … resonance imaging; DTX, Docetaxel; COF, Covalent organic framework … Nanotechnology-based drug delivery for breast cancer treatment: current … therapies using nanoplatforms. Pharmaceutics. 2025;17(3): …
-
AB Science receives notice of allowance for US patent covering masitinib in the treatment of metastatic castrate resistant prostate cancer
29 Jan 2026 17:00 GMT
… docetaxel, and no drug in combination with docetaxel or replacement of docetaxel … abiraterone treatment or were indicated for docetaxel treatment, and … Science is a pharmaceutical company specializing in … developed for human medicine in oncology, neurological …
-
<![CDATA[Erleada Shows Survival Advantage in Real-World Study of Metastatic Prostate Cancer]]>
02 Feb 2026 19:52 GMT
… , director of Genitourinary Medical Oncology Program, Winship … than in controlled trial settings. Investigators identified … randomized clinical trials by showing how treatments work in … apalutamide) versus darolutamide without docetaxel through 24 months, by …
-
<![CDATA[Apalutamide Reduces Risk of Death by 51% in Metastatic CSPC]]>
02 Feb 2026 18:12 GMT
… (Nubeqa) without docetaxel for the treatment of patients with … was designed to meet FDA guidance. Patients were identified … multinational, double-blind TITAN trial (NCT02489318).
After a … director of the Genitourinary Medical Oncology Program at Winship …
-
<![CDATA[Evidence-informed management of metastatic castration-sensitive prostate cancer]]>
29 Jan 2026 15:44 GMT
… evolving clinical trial data have reshaped treatment paradigms, … adverse-event profiles, drug–drug interactions, monitoring requirements, … and triplet approaches
Docetaxel chemotherapy remains an … Early involvement of medical oncology, radiation oncology, …
-
AB Science reçoit un avis d'autorisation pour un brevet américain couvrant le masitinib dans le traitement du cancer de la prostate métastatique hormono-resistant
29 Jan 2026 17:00 GMT
… ;un seul médicament de chimiothérapie enregistré, le docétaxel, et aucun médicament en association … LBA02-11 Masitinib plus docetaxel as first-line treatment of metastatic castrate … , AB Science est une société pharmaceutique spécialisée dans la recherche, le …